Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Icon ( (ICLR) ).
On May 27, 2025, ICON plc announced that its CEO, Dr. Steve Cutler, will present at the William Blair 45th Annual Growth Stock Conference on June 4, 2025. This participation underscores ICON’s strategic positioning in the clinical research industry, potentially enhancing its visibility and stakeholder engagement.
The most recent analyst rating on (ICLR) stock is a Buy with a $390.00 price target. To see the full list of analyst forecasts on Icon stock, see the ICLR Stock Forecast page.
Spark’s Take on ICLR Stock
According to Spark, TipRanks’ AI Analyst, ICLR is a Neutral.
Icon’s overall score reflects a mix of strong financial performance and efficient cash flow management, weighed down by technical indicators showing a bearish trend and a cautious outlook from the earnings call. The valuation is moderate, but the lack of dividend yield limits appeal for certain investors. The company’s focus on innovation and partnerships provides a potential for mid-to-long-term growth, but current market challenges and revenue declines pose significant risks.
To see Spark’s full report on ICLR stock, click here.
More about Icon
ICON plc is a leading clinical research organization headquartered in Dublin, Ireland, specializing in healthcare intelligence. The company provides outsourced services to pharmaceutical, biotechnology, medical device, and government and public health organizations, advancing clinical research from molecule to medicine. As of March 31, 2025, ICON employed approximately 41,250 employees across 97 locations in 55 countries.
Average Trading Volume: 1,482,869
Technical Sentiment Signal: Sell
Current Market Cap: $10.34B
See more data about ICLR stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue